It was found that ACT T cells pre-loaded with CD45-targeting TGF-βI liposomes ex vivo led to superior tumor infiltration of ACT T cells than those backpacked with CD90-targeting liposomes and reduction of tumor size in a B16F10 melanoma murine model. Here, THY1 is linked to neoplasm.